M&A in the pharmaceutical industry: is bigger always better?: Motives for M&A in big pharma and their effect on innovation

Additional Metadata
Keywords	Mergers and acquisitions (M&A), Pharmaceutical industry/market/sector, Innovation, Research and development (R&D)
Thesis Advisor	Wolf, P. de, Dittrich, K.
Persistent URL	hdl.handle.net/2105/21983
Series	International Management CEMS
Organisation	Rotterdam School of Management
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Gabedov, A.V. (2015, February 17). M&A in the pharmaceutical industry: is bigger always better?: Motives for M&A in big pharma and their effect on innovation. International Management CEMS. Retrieved from http://hdl.handle.net/2105/21983

M&A in the pharmaceutical industry: is bigger always better?